Cohance Lifesciences completes USFDA inspection.

Cohance Lifesciences completes USFDA inspection. The company has announced the successful completion of a USFDA inspection at its facility. This regulatory milestone indicates compliance readiness for export markets. No observations or adverse findings were reported during the audit.

📊 STOCKS: $COHANCE | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Regulatory